Ocugen (OCGN) Net Equity Issued and Repurchased (2015 - 2026)
Ocugen (OCGN) posted Net Equity Issued and Repurchased of $22.5 million for Q1 2026, up 1372.51% on a QoQ basis from $1.5 million in Q4 2025.
Ocugen (OCGN) Net Equity Issued and Repurchased (2015 - 2026) Analysis & Trends
Ocugen's Net Equity Issued and Repurchased history runs 10 years deep, the most recent figure standing at $22.5 million for Q1 2026.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $22.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.0 million (up 2835.33% YoY) and the FY2025 annual result came in at $19.9 million, down 48.51% from the prior year.
- Net Equity Issued and Repurchased was $22.5 million for Q1 2026 at Ocugen, up from $1.5 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $50.2 million in Q1 2022 and bottomed at -$145000.0 in Q1 2024.
- A 5-year average of $8.8 million and a median of $1.3 million in 2024 frame the typical range for Net Equity Issued and Repurchased.
- Peak annual rise in Net Equity Issued and Repurchased reached 6031.25% in 2024, while the deepest fall reached 102.53% in 2024.
- Ocugen's Net Equity Issued and Repurchased stood at $8.4 million in 2022, then plunged by 99.81% to $16000.0 in 2023, then surged by 6031.25% to $981000.0 in 2024, then surged by 55.76% to $1.5 million in 2025, then jumped by 1372.51% to $22.5 million in 2026.
- Business Quant data shows OCGN's Net Equity Issued and Repurchased at $22.5 million in Q1 2026, $1.5 million in Q4 2025, and $981000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | 22.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.50 Mn |
| Mar 31, 2026 | 22.50 Mn |
| Dec 31, 2025 | 1.53 Mn |
| Dec 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 981,000.00 |
| Dec 31, 2024 | 981,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | 98,000.00 |
| Sep 30, 2023 | 98,000.00 |
| Jun 30, 2023 | 14.96 Mn |
| Jun 30, 2023 | 14.96 Mn |
| Mar 31, 2023 | 5.73 Mn |
| Mar 31, 2023 | 5.73 Mn |
| Dec 31, 2022 | 8.43 Mn |
| Dec 31, 2022 | 8.43 Mn |
| Sep 30, 2022 | 603,000.00 |
| Sep 30, 2022 | 603,000.00 |